Journal of cachexia, sarcopenia and muscle
-
J Cachexia Sarcopenia Muscle · Nov 2021
Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort study.
Patients with end-stage renal disease may display both a loss of skeletal muscle mass and an increase in muscle fat deposits. We aimed to analyse the impact of low skeletal muscle mass index (SMI, surrogate marker of sarcopenia) and low muscle density (MD, surrogate marker of myosteatosis) on patient survival after kidney transplantation (KT). ⋯ Myosteatosis, which was more prevalent than low skeletal muscle mass, might be an important prognostic marker in patients undergoing KT.